Advertisement

The Nutshell

» stem cells

Daily News Roundup

Most Recent

image: Lawsuit Claims Stem Cells Unsafe

Lawsuit Claims Stem Cells Unsafe

By | July 18, 2014

A former employee complains that StemCells, Inc., fired him after he blew the whistle on improper manufacturing practices that could endanger patients.

0 Comments

image: Stem Cells for Autism?

Stem Cells for Autism?

By | July 15, 2014

Scientists express mixed enthusiasm over a trial to use cord blood stem cells as a treatment for autism.

0 Comments

image: Week in Review: June 30–July 4

Week in Review: June 30–July 4

By | July 4, 2014

STAP retractions; comparing SCNT-derived stem cells with iPSCs; malaria-infected mice more attractive to mosquitoes; stem cell banks face business challenges

0 Comments

image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

0 Comments

image: STAP Papers Retracted

STAP Papers Retracted

By | July 2, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Week in Review: June 9–13

Week in Review: June 9–13

By | June 13, 2014

Ancient apoptotic pathway connects humans to coral; lab-grown, light-sensing retinal tissue; tracking cancer with synthetic phospholipids; diving deep into the lung microbiome

0 Comments

image: Week in Review: June 2–6

Week in Review: June 2–6

By | June 6, 2014

The malnourished microbiome; innate immunity and beige fat; tools for stem cell self-renewal; predicting tomorrow’s PIs; MERS update

0 Comments

image: Final Straw for STAP?

Final Straw for STAP?

By | June 4, 2014

Independent analysis uncovers suspected mouse cell mix-up, while stimulus-triggered acquisition of pluripotency lead author Haruko Obokata agrees to retract the work in full.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: Diseased Heart Chip

Diseased Heart Chip

By | May 12, 2014

In the latest iteration of organ-on-a-chip technology, researchers develop an in vitro model of functioning human heart tissue with an inherited cardiovascular disease.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies